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The product of a Hastings Center project on ethical decision
making for newborn screening, Ethics and Newborn Genetic
Screening: New Technologies, New Challenges should be
required reading for all those concerned with the evolution
of infant screening and, more broadly, children’s health
policy. Although not all contributions to the edited volume
are equally compelling, the book brings together some of
the best minds and clearest thinking on the issues at stake.
A reasonable conclusion is that the recent expansion of
newborn screening in the US—and in all jurisdictions
(including my own province of Ontario, Canada) that have
followed the lead of the deeply ﬂawed American College of
MedicalGenetics report, ‘‘TowardaUniformScreeningPanel
and System’’—is without moral justiﬁcation.
Noting the distressing concurrence in one US state of an
expansion in the mandatory newborn screening panel
(with corollary demands on Medicaid funds) and an
appalling rise in infant mortality rates (alongside restric-
tions in Medicaid funds), the editors argue that newborn
screening policy is only ethically acceptable when it (1) is
evidence based; (2) considers the opportunity costs of its
investments; (3) seeks to fairly distribute costs and beneﬁts;
and (4) respects human rights. An important conclusion of
this moral framework is that newborn screening policy
should be removed from its silo and made to defend itself
alongside all other investments that might support the
imperative of improved infant and child health. Onemight
quibble that such moral ends are more typically advanced
by health economists, clinical epidemiologists, and polit-
ical philosophers than bioethicists, but there is no doubt
in this reviewer’s mind that these are the correct metrics.
American developments are the focus and overarching
concern of all contributors. Newborn screening in the US
is typically mandatory, and several authors dwell on this
distinctive legal approach. In Canada newborn screening
is pursued under the auspices of implied consent. Other
jurisdictions (The Netherlands) have moved to more
explicit consent processes even while infant screening
remains highly recommended. In all of these jurisdictions,
newborn screening initiatives seek to minimize parental
discretion. The moral justiﬁcation for this is that infant
screening is effective and necessary, indeed essential. Yet
in the absence of evidence on the effectiveness of
screening for many newly added conditions, expanded
panels abrogate the social contract wherein minimal
parental discretion is justiﬁed by the demonstrated effec-
tiveness of screening—whatever the jurisdiction or enroll-
ment mechanism. However, the editors do highlight a
distinctivemoral challenge in the US: unlike other jurisdic-
tions, the US lacks coherent mechanisms to fairly allocate
the costs of screening or ensure that families receiving
positive screening results (including affected infants,
false-positive cases, and the growing cohort of infants
with uncertain diagnoses) are guaranteed appropriate
care. Under these circumstances, the burden of proof for
those who would seek to expand screening panels should
be very high indeed. The books’ editors have ceded some
space to the proponents of expansion, but the weight of
commentary is decisive in its dissent. Those in the US,
and those profoundly inﬂuenced by US developments,
can only hope that advocates, health professionals, and
policy makers will agree.
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